サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ペプチド治療薬の世界市場規模：投与経路、タイプ、用途、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1090013

ペプチド治療薬の世界市場規模：投与経路、タイプ、用途、地域別の予測（2022年～2028年）

Global Peptide Therapeutics Market Size study, By Route of Administration, By Type, By Application, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
ペプチド治療薬の世界市場規模：投与経路、タイプ、用途、地域別の予測（2022年～2028年）
出版日: 2022年06月07日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がんや代謝異常の発症率上昇、新薬導入、医療活動への支出増加が、世界市場の成長を牽引する顕著な要因です。

しかし、医薬品承認のための厳しい規制負担と医薬品開発の高コストが、2022年～2028年の間の予測期間中の市場成長を妨げる見通しです。また、研究開発活動の高まりと技術進歩が、予測期間中の市場需要を促進すると予測されます。

当レポートでは、世界のペプチド治療薬市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のペプチド治療薬市場の定義と範囲

第3章 世界のペプチド治療薬市場力学

  • ペプチド治療薬市場影響分析（2020年～2028年）

第4章 世界のペプチド治療薬市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界のペプチド治療薬市場：投与経路別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：投与経路別
  • 市場推計と予測：投与経路別（2018年～2028年）
  • サブセグメント分析
    • 非経口経路
    • 経口経路
    • 経肺
    • 粘膜
    • その他

第7章 世界のペプチド治療薬市場：タイプ別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：タイプ別
  • 市場推計と予測：タイプ別（2018年～2028年）
  • サブセグメント分析
    • ジェネリック
    • 新薬

第8章 世界のペプチド治療薬市場：用途別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：用途別
  • 市場推計と予測：用途別（2018年～2028年）
  • サブセグメント分析
    • がん
    • 心血管疾患
    • 中枢神経系
    • 感染症
    • 呼吸器疾患
    • その他の用途

第9章 世界のペプチド治療薬市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • Eli Lilly and Company
    • Pfizer, Inc.
    • Amgen, Inc.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceuticals Industries Ltd.
    • Lonza Inc.
    • Sanofi
    • Bristol-Myers Squibb(BMS)
    • AstraZeneca PLC
    • Novartis AG

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Peptide Therapeutics Market, report scope
  • TABLE 2. Global Peptide Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Peptide Therapeutics Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
  • TABLE 4. Global Peptide Therapeutics Market estimates & forecasts by Type 2018-2028 (USD Million)
  • TABLE 5. Global Peptide Therapeutics Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 6. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Peptide Therapeutics Market
  • TABLE 56. List of primary sources, used in the study of global Peptide Therapeutics Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Peptide Therapeutics Market, research methodology
  • FIG 2. Global Peptide Therapeutics Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Peptide Therapeutics Market, key trends 2021
  • FIG 5. Global Peptide Therapeutics Market, growth prospects 2022-2028
  • FIG 6. Global Peptide Therapeutics Market, porters 5 force model
  • FIG 7. Global Peptide Therapeutics Market, pest analysis
  • FIG 8. Global Peptide Therapeutics Market, value chain analysis
  • FIG 9. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Peptide Therapeutics Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Peptide Therapeutics Market, regional snapshot 2018 & 2028
  • FIG 15. North America Peptide Therapeutics Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Peptide Therapeutics Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Peptide Therapeutics market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Peptide Therapeutics Market 2018 & 2028 (USD Million)
  • FIG 19. Global Peptide Therapeutics Market, company market share analysis (2021)
目次

Global Peptide Therapeutics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Peptide therapeutics are a type of polypeptides or peptides that is primarily used to cure a wide range of diseases such as cancer, cardiovascular diseases, infections, respiratory disorders, and many others. The growing incidences of cancer and metabolic disorders, the introduction of novel drugs, and increasing spending on healthcare activities are some prominent factors excelling the global market growth. For instance, according to the National Cancer Institute, the number of cancer patients is expected to rise to 29.5 million cases by the year 2040 from 18.1 million cases in the year 2018. Consequentially, the growing cases of cancer are fueling the demand for the Peptide Therapeutics, which, in turn, augments the market growth across the globe. However, the imposition of stringent regulations for drug approval and the high cost of developing drugs impede the growth of the market over the forecast period of 2022-2028. Also, the rising research and development activities and technological advancements are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Peptide Therapeutics Market study include: Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growth of the biotechnology industry and rising focus on the introduction of novel drugs. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing investments in research and development activities, and the rising incidences of cancer, would create lucrative growth prospects for the Peptide Therapeutics Market across the Asia-Pacific region.

Major market players included in this report are:

  • Eli Lilly and Company
  • Pfizer, Inc.
  • Amgen, Inc.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals Industries Ltd.
  • Lonza Inc.
  • Sanofi
  • Bristol-Myers Squibb (BMS)
  • AstraZeneca PLC
  • Novartis AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route of Administration:

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

By Type:

  • Generic
  • Innovative

By Application:

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Infections
  • Respiratory Disorders
  • Other Applications

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2018, 2019, 2020
  • Base year - 2021
  • Forecast period - 2022 to 2028

Target Audience of the Global Peptide Therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Peptide Therapeutics Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Peptide Therapeutics Market, by Route of Administration, 2020-2028 (USD Million)
    • 1.2.3. Peptide Therapeutics Market, by Type, 2020-2028 (USD Million)
    • 1.2.4. Peptide Therapeutics Market, by Application, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Peptide Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Peptide Therapeutics Market Dynamics

  • 3.1. Peptide Therapeutics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidences of cancer and metabolic disorder
      • 3.1.1.2. Introduction of novel drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Imposition of stringent regulations for drug approval
      • 3.1.2.2. High cost of developing drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising research and development activities
      • 3.1.3.2. Technological advancements

Chapter 4. Global Peptide Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Peptide Therapeutics Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Peptide Therapeutics Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Peptide Therapeutics Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
  • 6.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Parenteral Route
    • 6.4.2. Oral Route
    • 6.4.3. Pulmonary
    • 6.4.4. Mucosal
    • 6.4.5. Others

Chapter 7. Global Peptide Therapeutics Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Peptide Therapeutics Market by Type, Performance - Potential Analysis
  • 7.3. Global Peptide Therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 7.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Generic
    • 7.4.2. Innovative

Chapter 8. Global Peptide Therapeutics Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Peptide Therapeutics Market by Application, Performance - Potential Analysis
  • 8.3. Global Peptide Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
  • 8.4. Peptide Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Cancer
    • 8.4.2. Cardiovascular Diseases
    • 8.4.3. Central Nervous Systems
    • 8.4.4. Infections
    • 8.4.5. Respiratory Disorders
    • 8.4.6. Other Applications

Chapter 9. Global Peptide Therapeutics Market, Regional Analysis

  • 9.1. Peptide Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Peptide Therapeutics Market
    • 9.2.1. U.S. Peptide Therapeutics Market
      • 9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Application breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Peptide Therapeutics Market
  • 9.3. Europe Peptide Therapeutics Market Snapshot
    • 9.3.1. U.K. Peptide Therapeutics Market
    • 9.3.2. Germany Peptide Therapeutics Market
    • 9.3.3. France Peptide Therapeutics Market
    • 9.3.4. Spain Peptide Therapeutics Market
    • 9.3.5. Italy Peptide Therapeutics Market
    • 9.3.6. Rest of Europe Peptide Therapeutics Market
  • 9.4. Asia-Pacific Peptide Therapeutics Market Snapshot
    • 9.4.1. China Peptide Therapeutics Market
    • 9.4.2. India Peptide Therapeutics Market
    • 9.4.3. Japan Peptide Therapeutics Market
    • 9.4.4. Australia Peptide Therapeutics Market
    • 9.4.5. South Korea Peptide Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Peptide Therapeutics Market
  • 9.5. Latin America Peptide Therapeutics Market Snapshot
    • 9.5.1. Brazil Peptide Therapeutics Market
    • 9.5.2. Mexico Peptide Therapeutics Market
  • 9.6. Rest of The World Peptide Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Eli Lilly and Company
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Pfizer, Inc.
    • 10.2.3. Amgen, Inc.
    • 10.2.4. Takeda Pharmaceutical Company Limited
    • 10.2.5. Teva Pharmaceuticals Industries Ltd.
    • 10.2.6. Lonza Inc.
    • 10.2.7. Sanofi
    • 10.2.8. Bristol-Myers Squibb (BMS)
    • 10.2.9. AstraZeneca PLC
    • 10.2.10. Novartis AG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption